Nanotechnology and AI: Implications for Future of Personalized Cancer Care by Nucleic Acid Delivery

The convergence of nanotechnology and artificial intelligence (AI) has sparked a revolution in personalized cancer care. This chapter explores the synergistic potential of nanotechnology and AI in transforming the landscape of cancer treatment. Nanotechnology offers precise delivery of therapeutic payloads to tumor sites, minimizing off-target effects and enhancing drug efficacy. Coupled with AI-driven analytics, this approach enables real-time monitoring of treatment response and the adaptation of therapies based on individual patient profiles. Moreover, AI algorithms facilitate the identification of biomarkers for early detection and prognostication, aiding in patient stratification and treatment selection. By integrating nanotechnology and AI, the future of personalized cancer care holds promise for improved outcomes and enhanced patient well-being.